MK-4827, a PARP-1/-2 inhibitor, strongly enhances response of human lung and breast cancer xenografts to radiation

作者：Li Wang, Kathy A. Mason, K. Kian Ang, Thomas A. Buchholz, David R. Valdecanas, Anjili Mathur, Carolyn Buser‐Doepner, Carlo Toniatti, Luka Milas · 发表于：Investigational New Drugs · 年份：2011 · DOI：10.1007/s10637-011-9770-x · 被引用次数：86 · 研究领域：PARP inhibition in cancer therapy、DNA Repair Mechanisms、Cell death mechanisms and regulation